Clinical Trials Directory

Trials / Completed

CompletedNCT01688622

Glypican4 and CTRP5 in Metabolic Syndrome and the Effect of Exercise on These Adipokines

Effects of Exercise on Glypican4,CTRP3,5 and RBP4 Levels and Circulating Levels of These Adipokines in the Subjects With or Without Metabolic Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Korea University · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Accepted

Summary

Glypican4, CTRP3, CTRP5 are emerging novel adipokines mediating obesity and inflammation related disorders. RBP4 and adiponectin are well known important adipokines. Therefore, we examine the circulating levels of theses adipokines in the subjects with or without metabolic syndrome. Furthermore, we tried to clarify the effect of exercise on the circulating these adipokines.

Conditions

Interventions

TypeNameDescription
BEHAVIORAL3months Exercisetraining session consisting of a brief warm-up, followed by an approximately 45-min session of aerobic exercise at an intensity of 60-75% of the age-predicted maximum heart rate (approximately 300 kcal/day) and a 20-min muscle strength train- ing programme (approximately 100 kcal/day), followed by a brief cool-down period.

Timeline

Start date
2012-07-01
Primary completion
2012-09-01
Completion
2012-09-01
First posted
2012-09-20
Last updated
2012-09-21

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01688622. Inclusion in this directory is not an endorsement.